• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

TANIGUCHI HIDETOSHI  谷口 英俊

ORCIDConnect your ORCID iD *help
Researcher Number 00622747
Other IDs
Affiliation (based on the past Project Information) *help 2015: 大阪大学, 医学(系)研究科(研究院), 招へい教員
2012 – 2014: 大阪大学, 医学(系)研究科(研究院), 助教
Review Section/Research Field
Principal Investigator
Embryonic/Neonatal medicine
Keywords
Principal Investigator
低酸素性脳症 / 新生児 / 脳血管内皮細胞 / 低体温療法 / 血管内皮細胞 / プロスタグランジン / 新生児低酸素性虚血性脳症 / 低酸素生虚血性脳症 / iPS細胞 / 低酸素性虚血性脳症 / プロスタグランディン
  • Research Projects

    (1 results)
  • Research Products

    (5 results)
  • Co-Researchers

    (3 People)
  •  Development of cerebrovascular protection therapy for neonatal hypoxic ischemic encephalopathyPrincipal Investigator

    • Principal Investigator
      TANIGUCHI HIDETOSHI
    • Project Period (FY)
      2012 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Embryonic/Neonatal medicine
    • Research Institution
      Osaka University

All 2016 2014 2013 2012

All Journal Article Presentation

  • [Journal Article] Systematic cellular disease models reveal synergistic interactions of trisomy 21 and GATA1 mutations in hematopoietic abnormalities2016

    • Author(s)
      K. Banno, S. Omori, K. Hirata, N. Nawa, N. Nakagawa, K. Nishimura, M. Ohtaka, M. Nakanishi, T. Sakuma, T. Yamamoto, T. Toki, E. Ito, T. Yamamoto, C. Kokubu, J. Takeda, H. Taniguchi, H. Arahori, K. Wada, Y. Kitabatake and K. Ozono
    • Journal Title

      Cell Reports

      Volume: 15 Issue: 6 Pages: 1-15

    • DOI

      10.1016/j.celrep.2016.04.031

    • NAID

      120007135439

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-26461583, KAKENHI-PROJECT-14J04075, KAKENHI-PROJECT-24591601, KAKENHI-PROJECT-25461546, KAKENHI-PROJECT-25461643, KAKENHI-PROJECT-26253061, KAKENHI-PROJECT-15K15384, KAKENHI-PROJECT-26860799, KAKENHI-PROJECT-16K10090, KAKENHI-PROJECT-16K18478
  • [Journal Article] Protection by vascular prostaglandin E2 signaling in hypoxic-ischemic encephalopathy.2014

    • Author(s)
      Taniguchi H, Anacker C, Wang Q, Andreasson K
    • Journal Title

      Experimental Neurology

      Volume: 255C Pages: 30-37

    • DOI

      10.1016/j.expneurol.2014.02.012

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591601
  • [Journal Article] プロスタグランジン受容体作動薬による脳血管内皮細胞保護療法 ―低酸素虚血受傷後の脳へのライフライン確保を目指す薬物治療アプローチ―2013

    • Author(s)
      谷口英俊
    • Journal Title

      周産期学シンポジウム抄録集

      Volume: 31 Pages: 55-59

    • Data Source
      KAKENHI-PROJECT-24591601
  • [Presentation] プロスタグランジン受容体作動薬による脳血管内皮細胞保護療法 -低酸素虚血受傷後の脳へのライフライン確保を目指す薬物治療アプローチ-2013

    • Author(s)
      谷口英俊
    • Organizer
      第31回 周産期学シンポジウム 「成熟児のasphyxiaとcerebral palsy」
    • Place of Presentation
      大阪
    • Data Source
      KAKENHI-PROJECT-24591601
  • [Presentation] Cerebrovascular protection targeting EP receptors achieves infarct reduction in the model of neonatal hypoxic ischemic encephalopathy.2012

    • Author(s)
      谷口英俊
    • Organizer
      8th Hershey Conference on Developmental Brain Injury
    • Place of Presentation
      英国
    • Data Source
      KAKENHI-PROJECT-24591601
  • 1.  TANIIKE MASAKO (30263289)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 2.  WADA KAZUKO (30294094)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  KITABATAKE Yasuji
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi